Biotech Ciprofloxacin 250, 500, 750 250 mg, 500 mg or 750 mg FC tablets
PDF Leaflet Revision Date: 27 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Severe and/or complicated infections caused by ciprofloxacin sensitive bacteria.
Dosage (summary)
250-750 mg twice daily; duration varies by infection type.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding due to potential cartilage damage.
Key Drug Interactions
- QT prolonging drugs
- Tizanidine
- Methotrexate
- Theophylline
Contraindications
- Hypersensitivity to ciprofloxacin
- Pregnancy and lactation
- History of tendon disorders
- Myasthenia gravis
Common side effects
- Nausea
- Diarrhoea
- Tendinitis
- QT prolongation
Counselling Points
- Stay well hydrated to prevent crystalluria.
- Avoid dairy products close to dosing.
- Monitor for signs of tendon pain or swelling.
Serious warnings
- Risk of tendon rupture
- Potential for serious psychiatric reactions
- Photosensitivity
Important Disclaimer
The Biotech Ciprofloxacin 250, 500, 750 250 mg, 500 mg or 750 mg FC tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
